The Role of Thyroid Hormones in Heart Failure

Catarina Vale1, João Sérgio Neves1,2, Madalena von Hafe1

  • 1Departamento de Cirurgia e Fisiologia, Unidade de Investigação Cardiovascular, Faculdade de Medicina da Universidade do Porto, Alameda Professor Hernâni Monteiro, 4200-319, Porto, Portugal.

Insights

Thyroid hormone (TH) modulation shows promise for treating heart failure, especially heart failure with preserved ejection fraction (HFpEF). Supplementation may improve cardiac function and patient outcomes in this challenging condition.

Area of Science:

  • Cardiology
  • Endocrinology
  • Molecular Medicine

Background:

  • Cardiovascular diseases, particularly heart failure, represent a major global health burden with high mortality.
  • Heart failure with preserved ejection fraction (HFpEF) lacks effective treatments, and its prevalence varies significantly.
  • Thyroid hormones (TH) critically regulate cardiovascular function, and alterations in TH levels are common in heart failure patients.

Purpose of the Study:

  • To investigate the potential of thyroid hormones as a therapeutic target for heart failure.
  • To explore the role of thyroid dysfunction and local cardiac hypothyroidism in heart failure pathophysiology.
  • To review the evidence for TH supplementation in improving cardiac function and prognosis in heart failure.

Main Methods:

  • Review of epidemiological studies on thyroid hormone levels and heart failure risk/prognosis.
  • Analysis of experimental and clinical studies investigating TH supplementation in heart failure models and patients.
  • Examination of the mechanisms underlying TH action in the cardiovascular system and their alterations in heart failure.

Main Results:

  • Low thyroid hormone levels are associated with increased heart failure risk and poorer outcomes.
  • Epidemiological data and small clinical studies suggest TH supplementation may benefit cardiac function in heart failure.
  • Thyroid hormone levels can vary locally in the heart, potentially leading to cardiac hypothyroidism independent of serum levels.

Conclusions:

  • Thyroid hormone modulation is a promising therapeutic strategy for heart failure.
  • Further research is required to establish the safety and efficacy of TH supplementation in heart failure treatment.
  • Understanding local TH regulation in the heart may offer new avenues for HFpEF therapy.

Related Concept Videos

Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
5.6K
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
7.8K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.4K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
829
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
855
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
935